NPY2R (Neuropeptide Y Receptor Y2) encodes a G protein-coupled receptor that binds neuropeptide Y (NPY) with high affinity. This receptor is one of five NPY receptor subtypes (Y1, Y2, Y4, Y5, and y6) and plays a critical role in modulating neuroendocrine functions, energy homeostasis, stress responses, circadian rhythms, and importantly, [neurodegeneration](/diseases/neurodegeneration). The NPY2R is uniquely characterized by its preference for NPY(3-36) over NPY(1-36), and its widespread expression in the central nervous system and peripheral tissues makes it a key regulator of numerous physiological and pathological processes. Growing evidence implicates NPY2R in [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), stroke, and other neurodegenerative conditions[@baker2022][@wu2019][@kowalski2021].
Gene Overview
Protein Structure and Function
Structural Features
NPY2R is a 381-amino acid G protein-coupled receptor (GPCR) belonging to the class A rhodopsin family. The receptor contains:
Seven transmembrane domains (TM1-TM7): Form the characteristic GPCR barrel structure
Extracellular loops (ECL1-3): Contain disulfide bonds critical for ligand binding
Intracellular loops (ICL1-3): Couple to G proteins and contain phosphorylation sites
N-terminal extracellular domain: Short, contributes to ligand recognition
C-terminal intracellular tail: Contains serine/threonine residues for phosphorylation and β-arrestin recruitment
Ligand Binding Specificity
NPY2R exhibits unique pharmacological properties:
High affinity for NPY(3-36): Preferentially binds the C-terminal fragment of NPY
Lower affinity for NPY(1-36): Full-length NPY binds with reduced potency
PPY binding: Also binds peptide YY (PYY) with high affinity
Y1 vs Y2 distinction: The Y2 receptor lacks affinity for Y1-selective antagonists
Signaling Pathways
Upon ligand binding, NPY2R activates multiple signaling cascades:
Primary Signaling: Gi/Go Inhibition
Inhibition of adenylate cyclase: Reduces cAMP production
Activation of GIRK channels: Causes hyperpolarization
Inhibition of voltage-gated calcium channels: Reduces neurotransmitter release
Secondary Signaling Pathways
MAPK activation: ERK1/2 and p38 MAPK pathways
PI3K/Akt signaling: Pro-survival signaling
PLC activation: Phospholipase C-mediated signaling (in some cell types)
Expression and Localization
Central Nervous System Distribution
NPY2R is widely expressed throughout the brain:
High Expression Regions
Hypothalamus: Particularly the arcuate nucleus and paraventricular nucleus
Hippocampus: CA1-CA3 regions, dentate gyrus
Amygdala: Central nucleus, basolateral complex
Cortex: Layer II-III pyramidal neurons
Brainstem: Nucleus tractus solitarius
Cerebellum: Molecular layer interneurons
Moderate Expression
Thalamus: Specific relay nuclei
Striatum: Interneurons
Substantia nigra: Substantia nigra pars compacta and reticulata
Peripheral Tissue Expression
NPY2R is also expressed in:
Enteric nervous system: Myenteric and submucosal plexus
Cardiovascular system: Coronary arteries, heart
Adrenal medulla: Chromaffin cells
Immune cells: T lymphocytes, macrophages
Adipose tissue: White and brown adipocytes
Liver: Specific cell types
Role in Neurodegeneration
Alzheimer's Disease
NPY2R plays a complex role in [Alzheimer's Disease](/diseases/alzheimers-disease) pathogenesis:
NPY System Dysregulation in AD
NPY expression is increased in AD brains—likely as a compensatory response
NPY2R expression is altered in AD hippocampus and cortex
The NPY(3-36)/NPY2R system may modulate Aβ production and toxicity
Amyloid-Beta Interaction
NPY2R activation can modulate amyloid precursor protein (APP) processing
NPY signaling affects γ-secretase activity
NPY2R-mediated signaling may influence Aβ-induced neurotoxicity[@liu2021]
Tau Pathology
NPY2R activation affects tau phosphorylation pathways
Interaction with GSK-3β signaling has been reported
May influence tau propagation between neurons[@park2022]